OPCH - Option Care Health spikes after Q4 beat

Option Care Health (OPCH +9.2%) have recorded the biggest intraday gain since June 2021, after the infusion services provider posted better than expected financials for Q4 2021. The quarterly revenue climbed ~15% YoY to $927.2M expanding the full-year revenue ~13% YoY to $3.4B. Meanwhile, the net income rose more than four times from the previous year to reach $75.5M as the gross margin improved by 10bps to ~22.9%. The full-year net income stood at $139.9M compared to a net loss of $8.1M in the previous year as the gross margin improved by 20bps to ~22.7%. Despite the ongoing pandemic, the company served more than a quarter of a million patients in 2021, Chief Executive of Option Care (NASDAQ:OPCH) John C. Rademacher noted. The company expects to complete the acquisition of Specialty Pharmacy Nursing Network (SPNN) within this year. For 2022, Option Care (OPCH) projects $3.65B – $3.85B in net revenue and

For further details see:

Option Care Health spikes after Q4 beat